The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series:
Delivery of Drugs, Volume 2, 9780128177761
Drug Delivery Trends, Volume 3, 9780128178706
Drug Delivery Aspects, Volume 4, 9780128212226
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical propertiesJ.R. CAMPOS, P. SEVERINO, A. SANTINI, A.M. SILVA, RANJITA SHEGOKAR, S.B. SOUTO, AND E.B. SOUTO
2. Role of nanocarriers and their surface modification in targeting delivery of bioactive compounds
HENI RACHMAWATI, ATSARINA LARASATI, ANNIS CATUR ADI, AND RANJITA SHEGOKAR
3. Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy
KOBRA ROSTAMIZADEH AND VLADIMIR P. TORCHILIN
4. Nanoparticulate systems for wound healing
MAHA NASR, RIHAM I. EL-GOGARY, HEND ABD-ALLAH, AND MONA ABDEL-MOTTALEB
5. Solid dispersions: technologies used and future outlook
N.B. JADAV AND A. PARADKAR
6. Nanotoxicity: the impact of increasing drug bioavailability
JUAN BUENO
7. Nanoparticle-based vaccines: opportunities and limitations
DIANA DIAZ-AR�VALO AND MINGTAO ZENG
8. Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs
AN�ELKA B. KOVACEVIC
9. Nose-to-brain drug delivery: an alternative approach for effective brain drug targeting
AMIT ALEXANDER, MUKTA AGRAWAL, MAHAVIR BHUPAL CHOUGULE, SHAILENDRA SARAF, AND SWARNLATA SARAF
10. Trends in the intellectual property (IP) landscape of drug delivery systems: 30 years of growth and evolution
AMANDA STARLING-WINDHOF, ASUR SRINIVASAN, TINA TOMEO, ANNE MARIE CLARK, AND PETER MATTEI
Authors
Ranjita Shegokar Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany.Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
